Literature DB >> 10694243

Antagonism of calcium currents and neurotransmitter release by barium ions at frog motor nerve endings.

E M Silinsky1.   

Abstract

1. The effects of Ba(2+) (0.1 - 2 mM) on the component of the perineural voltage change associated with nerve terminal calcium currents (prejunctional Ca(2+) currents) were compared with the effects of this ion to antagonize calcium-dependent acetylcholine (ACh) release. These experiments were made on isolated neuromuscular junctions of the frog. 2. In the presence of sufficient concentrations of K(+) channel blockers to eliminate measurable prejunctional K(+) currents, low concentrations of Ba(2+) selectively antagonized prejunctional Ca(2+) currents in normal Ca(2+) solutions. Higher concentrations of Ba(2+) also substantially reduced the Na(+) component of the perineural waveform. 3. Ba(2+) inhibited the prolonged prejunctional Ca(2+) currents that developed in the presence of higher concentrations of K(+) channel blockers. 4. Simultaneous measurements of the prejunctional Ca(2+) currents and the electrophysiological correlates of ACh release (i.e. end-plate potentials, EPPs) were made under conditions of modest K(+) channel blockade. Under these conditions, Ba(2+) generally produced simultaneous decreases in both Ca(2+) currents and EPP amplitudes. In some instances, a prolongation of prejunctional Ca(2+) currents and a transient increase in EPP amplitudes preceded the decreases in both electrophysiological events. 5. These results suggest that Ba(2+) ions can antagonize the entry of calcium into motor nerve endings and this effect is likely to be responsible for the inhibitory effects of Ba(2+) on evoked ACh release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10694243      PMCID: PMC1571827          DOI: 10.1038/sj.bjp.0703036

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Effects of Anemonia sulcata toxin II on presynaptic currents and evoked transmitter release at neuromuscular junctions of the mouse.

Authors:  J Molgó; A Mallart
Journal:  Pflugers Arch       Date:  1985-12       Impact factor: 3.657

2.  Strategic location of calcium channels at transmitter release sites of frog neuromuscular synapses.

Authors:  R Robitaille; E M Adler; M P Charlton
Journal:  Neuron       Date:  1990-12       Impact factor: 17.173

3.  Effects of charybdotoxin, a blocker of Ca2+-activated K+ channels, on motor nerve terminals.

Authors:  A J Anderson; A L Harvey; E G Rowan; P N Strong
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

4.  Changes of quantal transmitter release caused by gadolinium ions at the frog neuromuscular junction.

Authors:  J Molgó; E del Pozo; J E Baños; D Angaut-Petit
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

Review 5.  The synaptic vesicle cycle: a cascade of protein-protein interactions.

Authors:  T C Südhof
Journal:  Nature       Date:  1995-06-22       Impact factor: 49.962

6.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

Review 7.  The biophysical pharmacology of calcium-dependent acetylcholine secretion.

Authors:  E M Silinsky
Journal:  Pharmacol Rev       Date:  1985-03       Impact factor: 25.468

8.  Calcium currents at motor nerve endings: absence of effects of adenosine receptor agonists in the frog.

Authors:  E M Silinsky; C S Solsona
Journal:  J Physiol       Date:  1992-11       Impact factor: 5.182

9.  A calcium-activated potassium current in motor nerve terminals of the mouse.

Authors:  A Mallart
Journal:  J Physiol       Date:  1985-11       Impact factor: 5.182

10.  On the simultaneous electrophysiological measurements of neurotransmitter release and perineural calcium currents from frog motor nerve endings.

Authors:  R S Redman; E M Silinsky
Journal:  J Neurosci Methods       Date:  1995-04       Impact factor: 2.390

View more
  1 in total

1.  The phosphatidylinositol 4-kinase inhibitor phenylarsine oxide blocks evoked neurotransmitter release by reducing calcium entry through N-type calcium channels.

Authors:  T J Searl; E M Silinsky
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.